Registry-listed formulations

PHENAZONE · chembl:CHEMBL277474

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Antipyrine and Benzocaine otic solutionRegistry intervention

    Molecular identity unconfirmed

    Separately studied ingredient; the full product remains distinct.

    View study and source
  • Antipyrine Otic SolutionRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)

Phase Distribution

Phase 2
1
100%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Completed(1)

Detailed Status

Completed1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 21 (100.0%)

Trials by Status

completed1100%

Recent Activity

0 active trials
Showing 1 of 1
completedphase_2

Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media

NCT02037893

Clinical Trials (1)

Showing 1 of 1 trials
NCT02037893Phase 2

Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media

Completed

All 1 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
1

External References

ChEMBL
CHEMBL277474

Names & Codes

Research Codes

NSC-7945